Forrest, Michael D. et al. published their patent in 2021 |CAS: 50743-01-6

The Article related to atp synthase reverse mode modifier disease treatment, Pharmacology: Other (All Agents and Effects Not Otherwise Assignable) and other aspects.Related Products of 50743-01-6

On January 25, 2021, Forrest, Michael D. published a patent.Related Products of 50743-01-6 The title of the patent was Therapeutic modifiers of the reverse mode of ATP synthase for treating diseases. And the patent contained the following:

Compounds that slow the ATP-hydrolyzing mode of ATP synthase are useful for treating various diseases and disorders including cancer, particularly cancers that utilize the Warburg effect. The experimental process involved the reaction of 5-Bromo-1H-imidazole-4-carbaldehyde(cas: 50743-01-6).Related Products of 50743-01-6

The Article related to atp synthase reverse mode modifier disease treatment, Pharmacology: Other (All Agents and Effects Not Otherwise Assignable) and other aspects.Related Products of 50743-01-6

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem